HEAL
Morningstar Rating™ - Overall rating out of 159 Health funds, based on risk-adjusted returns as of 07/31/2026
Reasons to Consider HEAL
High Growth Potential
The healthcare sector is under strain due to rising demand from an aging population and workforce shortages. Technology presents a viable solution, with the size of the HealthTech market expected to exceed $1T by 2032.1
Healthcare Innovators
The Fund invests in companies at the intersection of healthcare and technology across four key sub-themes: healthcare analytics and software, smart medical devices, AI drug discovery, and tech-enabled consumer healthcare.
Timely Opportunity
A growing range of technologies are set to advance patient care, evidenced by increased AI device approvals, lower drug development costs and optimized administrative processes that are improving clinical workflows.
1Global X ETFs Forecasts, Mar 2025
Key Information
As of Aug 20 2026ETF Summary
The Global X HealthTech ETF (HEAL) invests in companies transforming healthcare through cutting-edge technology. The fund targets four sub-themes: AI-enabled drug discovery, smart medical devices, tech-enabled consumer healthcare, and healthcare analytics and software solutions. Companies in these areas harness advanced technologies to enhance patient care, streamline operations, and drive medical breakthroughs. By focusing on tech-driven innovation, HEAL seeks to provide exposure to firms shaping the future of healthcare.
ETF Objective
The Global X HealthTech ETF (HEAL) seeks to provide investment results that correspond generally to the price and yield performance, before fees and expenses, of the Global X HealthTech Index.
| Trading Details |
| Distributions |
| Taxes |
ETF Prices
| NAV | Daily Change | |||
| Market Price | Daily Change |
Performance History
| Fund NAV | Market Price | Index | |
|---|---|---|---|
Top Holdings
| Net Assets (%) | Ticker | Name | SEDOL | Shares Held | Market Value |
|---|---|---|---|---|---|
| Exposure |
ETF Characteristics
As of Aug 19 2026| Return on Equity | 6.60% | |
| Weighted Avg. Market Cap | 16,322 M | |
| 2025 | 2026 | |
| Price-to-earnings | 374.19 | 68.03 |
| Price-to-book value | 4.69 | 4.26 |
ETF Risk Stats
As of Jul 31 2026| VERSUS | BETA |
|---|---|
| S&P 500 | 0.98 |
| NASDAQ-100 | 0.49 |
| MSCI EAFE | 0.64 |
| MSCI Emg. Mkts | 0.30 |
| Standard Deviation | 24.00% |